Funded Startups in Cranbury
Seven funded rounds in Cranbury, New Jersey span 2022-10-03 (Rocket Pharmaceuticals) through 2025-05-07 (Palatin Technologies), with most activity clusteri…
Seven funded rounds in Cranbury, New Jersey span 2022-10-03 (Rocket Pharmaceuticals) through 2025-05-07 (Palatin Technologies), with most activity clustering in the 2024–2025 window. Sector mix is biotech-heavy: 3 of 7 companies are in Biotechnology (Palatin Technologies on 2025-05-07 at $1M; Outlook Therapeutics on 2022-12-23 at $25M; Rocket Pharmaceuticals on 2022-10-03 at $100M). The disclosed round sizes are uneven, with Rocket Pharmaceuticals’ $100M (2022-10-03) acting as a clear outlier: all other disclosed amounts fall below $27M (e.g., IoTecha at $27M on 2024-06-10; Experic at $10M on 2024-09-25), while the smallest disclosed round is AffinIT’s $600K on 2025-05-02.
Stage labels are also skewed toward categories that are not specified: 4 of 7 entries use “Series Unknown” (Palatin Technologies, Experic, IoTecha, Outlook Therapeutics). The most recent 90 days contain two rounds in early May 2025 (Palatin Technologies at $1M on 2025-05-07; AffinIT at $600K on 2025-05-02), while 2024 includes three rounds (Reteta, Experic, IoTecha) between 2024-06-10 and 2024-10-02.
Most recent rounds
7 shownRelated listings
Frequently asked
What round size is the outlier in Cranbury, and how does it compare to the rest of the disclosed amounts?
Rocket Pharmaceuticals’ $100M round on 2022-10-03 is the only disclosed amount at $100M; the next-largest disclosed amounts are $27M (IoTecha on 2024-06-10) and $25M (Outlook Therapeutics on 2022-12-23), with the remainder below $10M (e.g., Experic at $10M on 2024-09-25; AffinIT at $600K on 2025-05-02).
Are rounds clustered in time within this Cranbury list?
Yes. There are three 2024 rounds—IoTecha ($27M) on 2024-06-10, Reteta ($2M) on 2024-10-02, and Experic ($10M) on 2024-09-25—while the two most recent entries fall within one week in May 2025 (AffinIT on 2025-05-02 and Palatin Technologies on 2025-05-07).
Which sectors are most represented among these 7 funded companies?
Biotechnology is the only sector appearing in 3+ entries: Palatin Technologies (2025-05-07, $1M), Outlook Therapeutics (2022-12-23, $25M), and Rocket Pharmaceuticals (2022-10-03, $100M). The other sectors represented once each are Financial Services (AffinIT), Artificial Intelligence (Reteta), Health Care (Experic), and Consumer Electronics (IoTecha).
How concentrated is stage information, and does it limit comparability across rounds?
Four of seven entries use “Series Unknown” (Palatin Technologies $1M on 2025-05-07; Experic $10M on 2024-09-25; IoTecha $27M on 2024-06-10; Outlook Therapeutics $25M on 2022-12-23). Only two named stages appear: Angel for AffinIT ($600K on 2025-05-02) and Seed for Reteta ($2M on 2024-10-02), plus one “Post-IPO Equity” entry for Rocket Pharmaceuticals ($100M on 2022-10-03).
Which entries fall closest to the current end of the date range shown?
Within the most recent window in the table, the latest date is 2025-05-07 (Palatin Technologies, Biotechnology, $1M). The other entry in that immediate period is AffinIT on 2025-05-02 (Financial Services, Angel, $600K), forming a two-round cluster in early May 2025.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.